Clinical Trial Update: Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases [NA]

View source ↗

Summary

This clinical trial update describes a project to develop RNA-Seq as a complementary diagnostic tool for rare diseases, with recruitment ongoing at the Mario Ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome
• Autosomal Dominant Polycystic Kidney Disease
• Membranoproliferative Glomerulonephritis

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis | NA | Status: RECRUITING